Effect of Local Anesthetic EMLA (Lidocaine 2.5% and Prilocaine 2.5%) Cream and Reduction in Dose, Pain and Intravenous Analgesic During Permanent Pacemaker Implantation

NCT02016976 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

40

Enrollment

OTHER_GOV

Sponsor class

Conditions

Pacemaker Implantation
Pain

Interventions

DRUG: EMLA Analgesic Cream
DRUG: Dormicum 2.5 mg and Pethidine 25 mg

Sponsor

Hillel Yaffe Medical Center